» Authors » Pawel Szymanski

Pawel Szymanski

Explore the profile of Pawel Szymanski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 84
Citations 569
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakonieczna A, Kwiatek M, Abramowicz K, Zawadzka M, Bany I, Glowacka P, et al.
Respir Res . 2025 Feb; 26(1):62. PMID: 39985005
Background: This study provides a detailed analysis of respiratory tract infections (RTIs) and immunity levels against influenza and SARS-CoV-2 among soldiers and military personnel in Poland. Owing to their unique...
2.
Zawadzka M, Lis A, Marszalkowska-Jakubik J, Szymanski P
Int J Occup Med Environ Health . 2025 Feb; 38(1):30-40. PMID: 39957472
Objectives: Cardiovascular diseases (CVDs) remain the leading cause of death in Europe. There are more and more young people and middle-aged patients with obesity, unrecognized hypertension and metabolic abnormalities. Professional...
3.
Krecisz P, Stefanska K, Studzinski J, Pitucha M, Czylkowska A, Szymanski P
J Med Chem . 2025 Feb; 68(3):2356-2376. PMID: 39895089
Of the 32 known copper isotopes, some have interesting properties for nuclear medicine, for example the short-lived Cu, Cu, Cu, the moderate long-lived Cu and the long-lived Cu. Due to...
4.
Czylkowska A, Pitucha M, Raducka A, Fornal E, Kordialik-Bogacka E, Scieszka S, et al.
Molecules . 2025 Jan; 30(1. PMID: 39795184
This paper presents the synthesis and characterization of new thiosemicarbazone derivatives with potential applications as antibacterial, antioxidant and anticancer agents. Six thiosemicarbazone derivatives (L-L5) were synthesized by reacting an appropriate...
5.
Kubica J, Adamski P, Gajda R, Kubica A, Ostrowska M, Casu G, et al.
Cardiol J . 2025 Jan; 32(1):83-89. PMID: 39776051
According to the ESC guidelines, cangrelor may be considered in P2Y12-inhibitor-naïve acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). The aim of this review is to summarize available...
6.
Kubica J, Adamski P, Ostrowska M, Kubica A, Gajda R, Badariene J, et al.
Int J Cardiol . 2024 Dec; 421():132897. PMID: 39647786
De-escalation of dual antiplatelet (DAPT) intensity may be considered in patients with high risk of bleeding after acute coronary syndrome. Some high risk patients after de-escalation may require antithrombotic therapy...
7.
Ostrowska M, Kasprzak M, Fabiszak T, Gajda J, Jaje-Rykowska N, Michalski P, et al.
PLoS One . 2024 Oct; 19(10):e0309922. PMID: 39436870
Background: Patients hospitalized due to Coronavirus disease 2019 (COVID-19) are still burdened with high risk of death. The aim of this study was to create a risk score predicting in-hospital...
8.
Hejna A, Marc M, Szymanski P, Mizera K, Barczewski M
Environ Sci Pollut Res Int . 2024 Oct; 31(50):60371-60388. PMID: 39382804
The study examined the degradation process of various types of polymers used to form models using the fused deposition modeling (FDM) and three-dimensional printing (3DP) methods and used in the...
9.
Zawadzka M, Lis A, Marszalkowska-Jakubik J, Szymanski P
Healthcare (Basel) . 2024 Sep; 12(17). PMID: 39273800
Exposure to harmful biological agents and the level of knowledge about specific risk factors are extremely important topics, especially among military personnel. This study evaluates the knowledge and perceptions of...
10.
Ostrowska M, Kasprzak M, Stolarek W, Grzelakowska K, Krys J, Kubica A, et al.
Rev Cardiovasc Med . 2024 Jul; 23(9):292. PMID: 39077718
Background: The coronavirus disease-2019 (COVID-19) pandemic is surging across Poland, leading to many direct deaths and underestimated collateral damage. We aimed to compare the influence of the COVID-19 pandemic on...